Celsion Corporation’s Heat Activated Liposomal Technology to be Featured in a Keynote Address at the International Nanotech and Biotechnology Innovation Conference

COLUMBIA, Md.--(BUSINESS WIRE)--Celsion Corporation (NASDAQ: CLSN) announced today that Professor David Needham Ph.D., Department of Engineering and Material Science, Duke University, will deliver a keynote address entitled “Design and Testing of Novel Thermally Sensitive Liposomal Formulations for Treatment of Local Tumors: A New Paradigm for Drug Delivery” on May 12 at 3:35 PM CET at the International Nanotech and Biotechnology Innovation Conference being held at the Carlsberg Akademi in Valby Denmark.

MORE ON THIS TOPIC